FDA Investigator

Sateesh Kum Sathigari

Latest inspection on record: San Diego, United States, May 2026 · records back to 2018

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 5 inspections across 5 sites are on record.
  • 19 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-22.

At a glance

Inspections

5

Sites

5

Observations

19

Career since

Jan 2018

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
PETNET SOLUTIONS, INC22 May 2026Human DrugsView 483 →
Molecular Imaging Program at Stanford17 Apr 2026Human DrugsView 483 →
APL HEALTHCARE LIMITED19 Apr 2019Human Drugs
Haupt Pharma Wuelfing GmbH10 Aug 2018Human DrugsView 483 →
Zhejiang Novus Pharmaceuticals Co. Ltd25 Jan 2018Human DrugsOn file

Sites inspected

PETNET SOLUTIONS, INCSan Diego, United States1 insp.
Molecular Imaging Program at StanfordPalo Alto, United States1 insp.
APL HEALTHCARE LIMITEDNaidupeta, India1 insp.
Haupt Pharma Wuelfing GmbHGronau (Leine), Germany1 insp.

Co-investigators

Investigators who share inspections with this person.

Anney Lin1 shared
Linda Thai1 shared
Brian J Ryan1 shared
Lisa B Orr1 shared
Liming Zhang1 shared

Full investigator report

Get the verbatim findings behind Sateesh Kum Sathigari's 19 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site